Compounds > 9-(2-hydroxy-3-nonyl)adenine

9-(2-hydroxy-3-nonyl)adenine and dideoxyadenosine

9-(2-hydroxy-3-nonyl)adenine has been researched along with dideoxyadenosine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorflinger, LJ; Schonbrunn, A1
Cristalli, G; Franchetti, P; Grifantini, M; La Colla, P; Marongiu, ME; Pani, A; Tinti, E1
Dickinson, NT; Haslam, RJ; Jang, EK1
Dubey, RK; Gillespie, DG; Jackson, EK1
Curry, FE; He, P; Zeng, M1
Anderson, BD; DeGraw, RT1

Other Studies

6 other study(ies) available for 9-(2-hydroxy-3-nonyl)adenine and dideoxyadenosine

ArticleYear
Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Endocrinology, 1985, Volume: 117, Issue:6

    Topics: Adenine; Adenosine; Adenosine Deaminase; Animals; Carbachol; Cell Line; Chromatography, High Pressure Liquid; Cyclic AMP; Deoxyadenosines; Dideoxyadenosine; Dipyridamole; Growth Hormone; Phenylisopropyladenosine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1985
Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
    The new microbiologica, 1995, Volume: 18, Issue:4

    Topics: Adenine; Adenosine Deaminase Inhibitors; Antiviral Agents; Cell Line; Coformycin; Dideoxyadenosine; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; HIV-1; Humans; Virus Replication

1995
Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.
    The Biochemical journal, 1997, Apr-15, Volume: 323 ( Pt 2)

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adenine; Blood Platelets; Cyclic AMP; Dideoxyadenosine; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Humans; Nitroprusside; Platelet Aggregation; Quinazolines

1997
Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2

    Topics: 2-Chloroadenosine; Adenine; Adenosine; Animals; Aorta, Thoracic; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytosol; Dideoxyadenosine; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Signal Transduction; Thionucleotides

1998
Dominant role of cAMP in regulation of microvessel permeability.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Adenosine Triphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Bradykinin; Calcium-Calmodulin-Dependent Protein Kinases; Capillaries; Capillary Permeability; Cyclic AMP; Cyclic GMP; Dideoxyadenosine; Enzyme Inhibitors; Female; Isoquinolines; Male; Mesenteric Veins; Rana pipiens; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Sulfonamides; Venules

2000
Enhanced oral bioavailability of 2'- beta-fluoro-2',3'-dideoxyadenosine (F-ddA) through local inhibition of intestinal adenosine deaminase.
    Pharmaceutical research, 2001, Volume: 18, Issue:9

    Topics: Adenine; Adenosine Deaminase Inhibitors; Algorithms; Animals; Anti-HIV Agents; Biological Availability; Biological Transport; Chemical Phenomena; Chemistry, Physical; Dideoxyadenosine; Enzyme Inhibitors; Intestinal Absorption; Intestines; Male; Rats; Rats, Sprague-Dawley

2001